Skip to main content
Clinical Trials/NCT02278159
NCT02278159
Completed
Not Applicable

Evaluation of the Integrated Home Dialysis Model

Princess Alexandra Hospital, Brisbane, Australia0 sites11,600 target enrollmentJanuary 2000

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Failure, Chronic
Sponsor
Princess Alexandra Hospital, Brisbane, Australia
Enrollment
11600
Primary Endpoint
Home dialysis survival
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to evaluate which home dialysis modality pattern (home hemodialysis [HHD], peritoneal dialysis [PD] or a combination of both, e.g. PD and then HHD) allows for the longest home dialysis survival, as defined by the time dialysed in a home environment. The investigators hypothesize that patients transferred from one home modality to another will have a longer home dialysis survival compared to patients treated only with PD or HHD.

Registry
clinicaltrials.gov
Start Date
January 2000
End Date
December 2012
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Princess Alexandra Hospital, Brisbane, Australia
Responsible Party
Principal Investigator
Principal Investigator

David Johnson

Director of Metro South and Ipswich Nephrology and Transplant Services (MINTS) Medical Director, Queensland Renal Transplant Services Professor of Medicine (University of Qld)

Princess Alexandra Hospital, Brisbane, Australia

Eligibility Criteria

Inclusion Criteria

  • Patients with PD/HHD 90 days after RRT initiation between January 1, 2000 and December 31, 2012 reported in ANZDATA
  • ≥ 18 years

Exclusion Criteria

  • Less than 90 days of dialysis
  • \< 18 years
  • Patients transferred to Australia/New Zealand after initiation of dialysis in another country

Outcomes

Primary Outcomes

Home dialysis survival

Time Frame: Survival analysis; specific analysis at 5 years after dialysis initiation

Time to first patient death or home dialysis technique failure for each home dialysis modalities, censored for transplantation and loss to follow-up

Secondary Outcomes

  • Patient survival, censored for technique failure(Survival analysis, specific analysis at 1,2 5 years after dialysis initiation)
  • Home technique survival, censored for death(survival analysis, specific analysis at 1,2 5 years after dialysis initiation)

Similar Trials